ERBB2 and breast carcinoma: Among the 348 breast cancer samples in this study, 162 (42.8 %) were luminal A, 84 (23.7 %) were luminal B, 27 (9.0 %) were HER-2 type, and 75 (24.5 %) were TNBC.